{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:14:35Z","timestamp":1779934475700,"version":"3.53.1"},"reference-count":67,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Molecular biology combined with genomics can be a powerful tool for developing potential intervention strategies for improving outcomes in children with autism spectrum disorders (ASD). Monogenic etiologies rarely cause autism. Instead, ASD is more frequently due to many polygenic contributing factors interacting with each other, combined with the epigenetic effects of diet, lifestyle, and environment. One limitation of genomics has been identifying ways of responding to each identified gene variant to translate the information to something clinically useful. This paper will illustrate how understanding the function of a gene and the effects of a reported variant on a molecular level can be used to develop actionable and targeted potential interventions for a gene variant or combinations of variants. For illustrative purposes, this communication highlights a specific genomic variant, SHANK3. The steps involved in developing molecularly genomically targeted actionable interventions will be demonstrated. Cases will be shared to support the efficacy of this strategy and to show how clinicians utilized these targeted interventions to improve ASD-related symptoms significantly. The presented approach demonstrates the utility of genomics as a part of clinical decision-making.<\/jats:p>","DOI":"10.3390\/ijms23042167","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T21:36:24Z","timestamp":1645047384000},"page":"2167","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder"],"prefix":"10.3390","volume":"23","author":[{"given":"Sharon","family":"Hausman-Cohen","sequence":"first","affiliation":[{"name":"IntellxxDNA, Austin, TX 78731, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-7419","authenticated-orcid":false,"given":"William","family":"LaValley","sequence":"additional","affiliation":[{"name":"LaValley MD Protocols, Austin, TX 78759, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Way","sequence":"additional","affiliation":[{"name":"The Australian Center for Genomic Analysis, Kenmore, QLD 4069, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Neuronutrition Associates, Austin, TX 78730, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Reeder","sequence":"additional","affiliation":[{"name":"IntellxxDNA, Austin, TX 78731, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"ref_1","unstructured":"(2020, March 25). \u201cWhat Is Autism Spectrum Disorder?\u201d Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/ncbddd\/autism\/facts.html."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Way, H., Williams, G., Hausman-Cohen, S., and Reeder, J. (2021). Genomics as a Clinical Decision Support Tool: Successful Proof of Concept for Improved ASD Outcomes. J. Pers. Med., 11.","DOI":"10.3390\/jpm11070596"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rao, R.V., Kumar, S., Gregory, J., Coward, C., Okada, S., Lipa, W., Kelly, L., and Bredesen, D.E. (2021). ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline. Biomedcines, 9.","DOI":"10.3390\/biomedicines9101348"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40142-021-00200-7","article-title":"Horizon Scanning in Cancer Genomics: How Advances in Genomic Medicine Will Change Cancer Care Over the Next Decade","volume":"9","author":"Seed","year":"2021","journal-title":"Curr. Genet. Med. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fncel.2019.00385","article-title":"Genetic Causes and Modifiers of Autism Spectrum Disorder","volume":"13","author":"Rylaarsdam","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.braindev.2012.05.013","article-title":"SHANK3 as an autism spectrum disorder-associated gene","volume":"35","author":"Uchino","year":"2013","journal-title":"Brain Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.celrep.2015.04.064","article-title":"Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators","volume":"11","author":"Duffney","year":"2015","journal-title":"Cell Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1523\/JNEUROSCI.2529-18.2019","article-title":"Deletion of Autism Risk Gene Shank3 Disrupts Prefrontal Connectivity","volume":"39","author":"Pagani","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ejhg.2012.175","article-title":"Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders","volume":"21","author":"Boccuto","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2011.57","article-title":"SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism","volume":"17","author":"Durand","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e22097","DOI":"10.1002\/syn.22097","article-title":"Autism-associated Shank3 mutations alter mGluR expression and mGluR-dependent but not NMDA receptor-dependent long-term depression","volume":"73","author":"Lee","year":"2019","journal-title":"Synapse"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.1523\/JNEUROSCI.2725-12.2013","article-title":"Shank3-Rich2 Interaction Regulates AMPA Receptor Recycling and Synaptic Long-Term Potentiation","volume":"33","author":"Raynaud","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/jnc.13709","article-title":"Activity and circadian rhythm influence synaptic Shank3 protein levels in mice","volume":"138","author":"Sarowar","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Alamilla, J., Ramiro-Cort\u00e9s, Y., Mej\u00eda-L\u00f3pez, A., Chavez, J.-L., Rivera, D.O., Felipe, V., and Aguilar-Roblero, R. (2021). Altered Light Sensitivity of Circadian Clock in Shank3+\/\u2013 Mouse. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.604165"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/074873049701200611","article-title":"Acute and Delayed Effects of Exercise on Human Melatonin Secretion","volume":"12","author":"Buxton","year":"1997","journal-title":"J. Biol. Rhythm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-3391-11-4","article-title":"A tryptophan-rich breakfast and exposure to light with low color temperature at night improve sleep and salivary melatonin level in Japanese students","volume":"11","author":"Wada","year":"2013","journal-title":"J. Circadian Rhythm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/07420528.2018.1527773","article-title":"Systematic review of light exposure impact on human circadian rhythm","volume":"36","author":"Partonen","year":"2019","journal-title":"Chronobiol. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40474-018-0147-0","article-title":"Melatonin and Comorbidities in Children with Autism Spectrum Disorder","volume":"5","author":"Gagnon","year":"2018","journal-title":"Curr. Dev. Disord. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fncel.2018.00374","article-title":"Dietary Zinc Supplementation Prevents Autism Related Behaviors and Striatal Synaptic Dysfunction in Shank3 Exon 13\u201316 Mutant Mice","volume":"12","author":"Fourie","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1523\/JNEUROSCI.0116-16.2016","article-title":"Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength","volume":"36","author":"Arons","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hagmeyer, S., Sauer, A.K., and Grabrucker, A.M. (2018). Prospects of Zinc Supplementation in Autism Spectrum Disorders and Shankopathies Such as Phelan McDermid Syndrome. Front. Synaptic Neurosci., 10.","DOI":"10.3389\/fnsyn.2018.00011"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fnmol.2018.00405","article-title":"Shank and Zinc Mediate an AMPA Receptor Subunit Switch in Developing Neurons","volume":"11","author":"Ha","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/srep00129","article-title":"Infantile zinc deficiency: Association with autism spectrum disorders","volume":"1","author":"Yasuda","year":"2011","journal-title":"Sci. Rep."},{"key":"ref_24","first-page":"1","article-title":"The Relationship between Zinc Levels and Autism: A Systematic Review and Meta-analysis","volume":"10","author":"Babaknejad","year":"2016","journal-title":"Iran. J. Child Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/s41380-018-0325-9","article-title":"A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability","volume":"25","author":"Wang","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Savoia, P., Fava, P., Casoni, F., and Cremona, O. (2019). Targeting the ERK Signaling Pathway in Melanoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061483"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/JIPO.JIPO_17_18","article-title":"Extracellular Signal-Regulated Kinase (ERK) Inhibitors in Oncology Clinical Trials","volume":"2","author":"Chin","year":"2019","journal-title":"J. Immunother. Precis. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1046\/j.1523-1755.2000.00265.x","article-title":"Anti-apoptotic effect of quercetin: Intervention in the JNK- and ERK-mediated apoptotic pathways","volume":"58","author":"Ishikawa","year":"2000","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.clinthera.2013.04.006","article-title":"An Open-Label Pilot Study of a Formulation Containing the Anti-Inflammatory Flavonoid Luteolin and Its Effects on Behavior in Children With Autism Spectrum Disorders","volume":"35","author":"Taliou","year":"2013","journal-title":"Clin. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.micpath.2017.09.029","article-title":"Resveratrol inhibits proliferation, promotes differentiation and melanogenesis in HT-144 melanoma cells through inhibition of MEK\/ERK kinase pathway","volume":"111","author":"Lei","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Malaguarnera, M., Khan, H., and Cauli, O. (2020). Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects. Antioxidants, 9.","DOI":"10.3390\/antiox9030188"},{"key":"ref_32","first-page":"1","article-title":"Curcumin Inhibits ERK\/c-Jun Expressions and Phosphorylation against Endometrial Carcinoma","volume":"2019","author":"Zhang","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/wps.20398","article-title":"Are there new advances in the pharmacotherapy of autism spectrum disorders?","volume":"16","author":"Hollander","year":"2017","journal-title":"World Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.fct.2013.10.028","article-title":"Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway","volume":"62","author":"Zuo","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e18904","DOI":"10.7554\/eLife.18904","article-title":"Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat","volume":"6","author":"Kay","year":"2017","journal-title":"eLife"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnsyn.2018.00017","article-title":"Oxytocin as a Modulator of Synaptic Plasticity: Implications for Neurodevelopmental Disorders","volume":"10","author":"Rajamani","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1097\/PR9.0000000000000861","article-title":"Increased pain sensitivity and pain-related anxiety in individuals with autism","volume":"5","author":"Failla","year":"2020","journal-title":"PAIN Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1177\/13623613211034375","article-title":"Oxytocin levels tend to be lower in autistic children: A meta-analysis of 31 studies","volume":"25","author":"John","year":"2021","journal-title":"Autism"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-021-00459-1","article-title":"A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome","volume":"12","author":"Fastman","year":"2021","journal-title":"Mol. Autism"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neubiorev.2020.12.028","article-title":"Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis","volume":"122","author":"Huang","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbi.2016.11.002","article-title":"Microbial lysate upregulates host oxytocin","volume":"61","author":"Varian","year":"2017","journal-title":"Br. Behav. Immun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1572-0241.2003.07458.x","article-title":"Fecal Lactoferrin Is A Sensitive and Specific Marker in Identifying Intestinal Inflammation","volume":"98","author":"Kane","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fpsyt.2017.00228","article-title":"Attention-Deficit\/Hyperactivity Disorder And Inflammation: What Does Current Knowledge Tell Us? A Systematic Review","volume":"8","author":"Anand","year":"2017","journal-title":"Front. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: An evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2147\/NDT.S147305","article-title":"Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: A meta-analysis of randomized controlled trials","volume":"13","author":"Cheng","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/nu2030355","article-title":"Omega-3 Fatty Acids and Inflammatory Processes","volume":"2","author":"Calder","year":"2010","journal-title":"Nutrients"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Masselli, E., Carubbi, C., Pozzi, G., Percesepe, A., Campanelli, R., Villani, L., Gobbi, G., Bonomini, S., Roti, G., and Rosti, V. (2021). Impact of the rs1024611 Polymorphism of CCL2 on the Pathophysiology and Outcome of Primary Myelofibrosis. Cancers, 13.","DOI":"10.3390\/cancers13112552"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Colizzi, M., Bortoletto, R., Costa, R., and Zoccante, L. (2021). Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence. Nutrients, 13.","DOI":"10.3390\/nu13041346"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Akhondzadeh, S., Mohammadi, M.-R., and Khademi, M. (2004). Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry, 4.","DOI":"10.1186\/1471-244X-4-9"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mahapatra, S., Vyshedsky, D., Mart\u00ednez, S., Kannel, B., Braverman, J., Edelson, S.M., Vyshedskiy, A., and Vyshedskiy, D. (2018). Autism Treatment Evaluation Checklist (ATEC) Norms: A \u201cGrowth Chart\u201d for ATEC Score Changes as a Function of Age. Children, 5.","DOI":"10.3390\/children5020025"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"32677","DOI":"10.1038\/srep32677","article-title":"TNF-\u03b1 -308 G > A (rs1800629) Polymorphism is Associated with Celiac Disease: A Meta-analysis of 11 Case-Control Studies","volume":"6","author":"Khan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/5409653","article-title":"Presence of DQ2.2 Associated with DQ2.5 Increases the Risk for Celiac Disease","volume":"2016","author":"Almeida","year":"2016","journal-title":"Autoimmune Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Croall, I., Hoggard, N., and Hadjivassiliou, M. (2021). Gluten and Autism Spectrum Disorder. Nutrients, 13.","DOI":"10.3390\/nu13020572"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.clinthera.2018.05.004","article-title":"Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes","volume":"40","author":"Ratnaseelan","year":"2018","journal-title":"Clin. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"109999","DOI":"10.1016\/j.pnpbp.2020.109999","article-title":"Polymorphism of interleukin-1\u03b2 and interleukin-1 receptor antagonist genes in children with autism spectrum disorders","volume":"103","author":"Saad","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/mp.2014.77","article-title":"The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: A meta-analysis","volume":"20","author":"LoParo","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pauletto, M., Tolosi, R., Giantin, M., Guerra, G., Barbarossa, A., Zaghini, A., and Dacasto, M. (2020). Insights into Aflatoxin B1 Toxicity in Cattle: An In Vitro Whole-Transcriptomic Approach. Toxins, 12.","DOI":"10.3390\/toxins12070429"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1182\/blood-2018-03-841023","article-title":"A common TCN1 loss-of-function variant is associated with lower vitamin B12 concentration in African Americans","volume":"131","author":"Hu","year":"2018","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11689-011-9077-4","article-title":"Glutathione pathway gene variation and risk of autism spectrum disorders","volume":"3","author":"Bowers","year":"2011","journal-title":"J. Neurodev. Disord."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1724600818792897","article-title":"Relationship between GSTP1 rs1695 gene polymorphism and myelosuppression induced by platinum-based drugs: A meta-analysis","volume":"33","author":"Lv","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1073\/pnas.2135229100","article-title":"The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses","volume":"100","author":"Vader","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ganz, A.B., Cohen, V.V., Swersky, C.C., Stover, J., Vitiello, G.A., Lovesky, J., Chuang, J.C., Shields, K., Fomin, V.G., and Lopez, Y.S. (2017). Genetic Variation in Choline-Metabolizing Enzymes Alters Choline Metabolism in Young Women Consuming Choline Intakes Meeting Current Recommendations. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020252"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/578429","article-title":"Dietary Intake and Plasma Levels of Choline and Betaine in Children with Autism Spectrum Disorders","volume":"2013","author":"Hamlin","year":"2013","journal-title":"Autism Res. Treat."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3945\/an.112.003038","article-title":"Zinc Biochemistry: From a Single Zinc Enzyme to a Key Element of Life","volume":"4","author":"Maret","year":"2013","journal-title":"Adv. Nutr. Int. Rev. J."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B.D., Hausman-Cohen, S., Attarha, M., and Chwa, W.J. (2021). Precision Medicine Approach to Alzheimer\u2019s Disease: Successful Proof-of-Concept Trial. medRxiv.","DOI":"10.1101\/2021.05.10.21256982"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7011a1","article-title":"Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years\u2014Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018","volume":"70","author":"Maenner","year":"2021","journal-title":"MMWR. Surveill. Summ."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/2167\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:20:36Z","timestamp":1760134836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/2167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23042167"],"URL":"https:\/\/doi.org\/10.3390\/ijms23042167","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]}}}